2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O8] Oral Session 8　Lung Cancer / Thoracic Cancer 2（Immune Checkpoint Inhibitors）
【E】

Fri. Feb 18, 2022 3:05 PM - 4:35 PM Room 2 and 3 (Annex 1 and 2, 1F, Kyoto International Conference Center)

Chair：Isamu Okamoto（Research Institute for Diseases of the Chest, Kyushu University），Kazuhisa Takahashi（Department of Respiratory Medicine, Juntendo University）
Discussant：Tatsuya Yoshida（Department of Thoracic Oncology, National Cancer Center Hospital）

[O8-6] KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma in Japan

○Takashi Kijima1, Terufumi Kato2, Yasushi Goto3, Takashi Yokoi1, Kozo Kuribayashi1, Koji Mikami1, Yasuko Fuchimoto4, Shuji Murakami2, Tatsuya Yoshida3, Masae Homma5, Akira Wakana5, Kazuo Noguchi5, Nobukazu Fujimoto6 (1.Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, 2.Department of Thoracic Oncology, Kanagawa Cancer Center, 3.Department of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Respiratory Medicine, Okayama Rosai Hospital, 5.MSD K.K., Tokyo, Japan, 6.Department of Medical Oncology, Okayama Rosai Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password